BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8843296)

  • 1. Uptake of cefepime by phagocytosing polymorphonuclear neutrophils and subsequent intracellular killing.
    Pruul H; McDonald PJ
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1870-4. PubMed ID: 8843296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefdinir-induced modification of the susceptibility of bacteria to the antibacterial activity of human serum and polymorphonuclear neutrophils.
    Pruul H; McDonald PJ
    Eur J Clin Microbiol Infect Dis; 1993 Mar; 12(3):170-6. PubMed ID: 8508815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of cefepime on the phagocytic killing of Staphylococcus aureus by human polymorphonuclear leucocytes and the determination of this effect by means of nitrite production.
    Sultan N; Cirak MY; Erbaş D
    Microbios; 2000; 103(405):97-106. PubMed ID: 11092191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of cefepime on opsonophagocytosis of bacteria.
    Raponi G; Keller N; Rozenberg-Arska M; Hoepelman IM; Verhoef J
    Drugs Exp Clin Res; 1989; 15(4):141-4. PubMed ID: 2673713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro bactericidal activity of cefepime and cefpirome against clinical isolates at Karachi.
    Arsalan A; Naqvi SB; Ali SA; Ahmed S; Shakeel O
    Pak J Pharm Sci; 2015 May; 28(3):841-7. PubMed ID: 26004702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between antibiotics and human neutrophils in the killing of staphylococci.
    Root RK; Isturiz R; Molavi A; Metcalf JA; Malech HL
    J Clin Invest; 1981 Jan; 67(1):247-59. PubMed ID: 7451652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of phagocytosis of bacteria on the uptake of sparfloxacin by human neutrophils.
    García I; Pascual A; Ballesta S; Perea EJ
    Chemotherapy; 1996; 42(6):465-7. PubMed ID: 8957582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of interactions between neutrophils and staphylococci by lysosomotropic weak bases.
    Styrt B; Klempner MS
    Infect Immun; 1985 Nov; 50(2):415-9. PubMed ID: 2997038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of five beta-lactam antibiotics against common nosocomial pathogens using the time above MIC at different creatinine clearances.
    Kays MB
    Pharmacotherapy; 1999 Dec; 19(12):1392-9. PubMed ID: 10600088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of phagocytic and chemiluminescence response of human polymorphonuclear neutrophils.
    Grebner JV; Mills EL; Gray GH; Quie PG
    J Lab Clin Med; 1977 Jan; 89(1):153-9. PubMed ID: 401517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of cefepime administered by intermittent and continuous infusion.
    Burgess DS; Hastings RW; Hardin TC
    Clin Ther; 2000 Jan; 22(1):66-75. PubMed ID: 10688391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phagocytic and postphagocytic activities of bovine neutrophils for pure and mixed bacterial cultures.
    Silva ID; Jain NC; Farver TB; Zinkl JG
    J Dairy Sci; 1988 Sep; 71(9):2513-9. PubMed ID: 3053812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Killing of phagocytosed Staphylococcus aureus by human neutrophils requires intracellular free calcium.
    Wilsson A; Lundqvist H; Gustafsson M; Stendahl O
    J Leukoc Biol; 1996 Jun; 59(6):902-7. PubMed ID: 8691076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meropenem-induced alteration of the susceptibility of Escherichia coli and Staphylococcus aureus to the bactericidal activity of human polymorphonuclear leucocytes.
    Herrera-Insúa I; Pérez P; Martínez P; Gómez-Lus ML; Prieto J
    J Antimicrob Chemother; 1997 Feb; 39(2):223-8. PubMed ID: 9069543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface phagocytosis of Staphylococcus epidermidis and Escherichia coli by human neutrophils: serum requirements for opsonization and chemiluminescence.
    Gordon DL; Avery VM; Rice JL; McDonald PJ
    FEMS Microbiol Immunol; 1989 Dec; 1(8-9):417-23. PubMed ID: 2697319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergism of cephalosporins at subinhibitory concentrations and polymorphonuclear leukocytes on phagocytic killing of Escherichia coli and its mode of action.
    Watanabe Y; Tawara S; Mine Y; Kikuchi H; Goto S; Kuwahara S
    J Antibiot (Tokyo); 1986 Feb; 39(2):294-303. PubMed ID: 3514564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small increases in pH decrease uptake of Escherichia coli by human neutrophils in vitro.
    Berger EM; Murphy K; Shibao GA; Repine JE
    Inflammation; 1988 Apr; 12(2):161-7. PubMed ID: 2839421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of rosmarinic acid on opsonization and intracellular killing of Escherichia coli and Staphylococcus aureus by porcine and human polymorphonuclear leucocytes.
    Verweij-van Vught AM; Appelmelk BJ; Groeneveld AB; Sparrius M; Thijs LG; MacLaren DM
    Agents Actions; 1987 Dec; 22(3-4):288-94. PubMed ID: 3328496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemiluminescence induced by phagocytosis of Escherichia coli by polymorphonuclear leucocytes.
    Fazeli A; Richards L
    J Gen Microbiol; 1984 Sep; 130(9):2267-75. PubMed ID: 6389762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of bacteria to serum lysis or phagocytosis following growth in subinhibitory levels of lincosaminide or spectinomycin related antibiotics.
    Cialdella JI; Vavra JJ; Marshall VP
    J Antibiot (Tokyo); 1986 Jul; 39(7):978-84. PubMed ID: 2944862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.